Literature DB >> 10644350

Role of the influenza virus M1 protein in nuclear export of viral ribonucleoproteins.

M Bui1, E G Wills, A Helenius, G R Whittaker.   

Abstract

The protein kinase inhibitor H7 blocks influenza virus replication, inhibits production of the matrix protein (M1), and leads to a retention of the viral ribonucleoproteins (vRNPs) in the nucleus at late times of infection (K. Martin and A. Helenius, Cell 67:117-130, 1991). We show here that production of assembled vRNPs occurs normally in H7-treated cells, and we have used H7 as a biochemical tool to trap vRNPs in the nucleus. When H7 was removed from the cells, vRNP export was specifically induced in a CHO cell line stably expressing recombinant M1. Similarly, fusion of cells expressing recombinant M1 from a Semliki Forest virus vector allowed nuclear export of vRNPs. However, export was not rescued when H7 was present in the cells, implying an additional role for phosphorylation in this process. The viral NS2 protein was undetectable in these systems. We conclude that influenza virus M1 is required to induce vRNP nuclear export but that cellular phosphorylation is an additional factor.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10644350      PMCID: PMC111655          DOI: 10.1128/jvi.74.4.1781-1786.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  37 in total

1.  Membrane association of influenza virus matrix protein does not require specific hydrophobic domains or the viral glycoproteins.

Authors:  E Kretzschmar; M Bui; J K Rose
Journal:  Virology       Date:  1996-06-01       Impact factor: 3.616

2.  Nuclear transport of influenza virus ribonucleoproteins: the viral matrix protein (M1) promotes export and inhibits import.

Authors:  K Martin; A Helenius
Journal:  Cell       Date:  1991-10-04       Impact factor: 41.582

3.  Nuclear trafficking of influenza virus ribonuleoproteins in heterokaryons.

Authors:  G Whittaker; M Bui; A Helenius
Journal:  J Virol       Date:  1996-05       Impact factor: 5.103

4.  Nuclear import and export of influenza virus nucleoprotein.

Authors:  G Neumann; M R Castrucci; Y Kawaoka
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

5.  Identification of a novel cellular cofactor for the Rev/Rex class of retroviral regulatory proteins.

Authors:  H P Bogerd; R A Fridell; S Madore; B R Cullen
Journal:  Cell       Date:  1995-08-11       Impact factor: 41.582

6.  Expression of recombinant plasmids in mammalian cells is enhanced by sodium butyrate.

Authors:  C M Gorman; B H Howard; R Reeves
Journal:  Nucleic Acids Res       Date:  1983-11-11       Impact factor: 16.971

7.  DNA-mediated transfer of the adenine phosphoribosyltransferase locus into mammalian cells.

Authors:  M Wigler; A Pellicer; S Silverstein; R Axel; G Urlaub; L Chasin
Journal:  Proc Natl Acad Sci U S A       Date:  1979-03       Impact factor: 11.205

8.  Inhibitory effect of protein kinase C inhibitor on the replication of influenza type A virus.

Authors:  M Kurokawa; H Ochiai; K Nakajima; S Niwayama
Journal:  J Gen Virol       Date:  1990-09       Impact factor: 3.891

9.  Nuclear import of microinjected influenza virus ribonucleoproteins.

Authors:  I Kemler; G Whittaker; A Helenius
Journal:  Virology       Date:  1994-08-01       Impact factor: 3.616

Review 10.  The nuclear matrix and virus function.

Authors:  W Deppert; R Schirmbeck
Journal:  Int Rev Cytol       Date:  1995
View more
  78 in total

1.  The packaging signal of influenza viral RNA molecules.

Authors:  S Tchatalbachev; R Flick; G Hobom
Journal:  RNA       Date:  2001-07       Impact factor: 4.942

2.  Restriction of viral replication by mutation of the influenza virus matrix protein.

Authors:  Teresa Liu; Zhiping Ye
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

3.  Generation of influenza A virus NS2 (NEP) mutants with an altered nuclear export signal sequence.

Authors:  Kiyoko Iwatsuki-Horimoto; Taisuke Horimoto; Yutaka Fujii; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

4.  Using single-particle tracking to study nuclear trafficking of viral genes.

Authors:  Hazen P Babcock; Chen Chen; Xiaowei Zhuang
Journal:  Biophys J       Date:  2004-10       Impact factor: 4.033

5.  Human immunodeficiency virus rev-binding protein is essential for influenza a virus replication and promotes genome trafficking in late-stage infection.

Authors:  Amie J Eisfeld; Gabriele Neumann; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2011-07-13       Impact factor: 5.103

6.  Crystal structure of the M1 protein-binding domain of the influenza A virus nuclear export protein (NEP/NS2).

Authors:  Hatice Akarsu; Wilhelm P Burmeister; Carlo Petosa; Isabelle Petit; Christoph W Müller; Rob W H Ruigrok; Florence Baudin
Journal:  EMBO J       Date:  2003-09-15       Impact factor: 11.598

7.  In vitro and in vivo replication of influenza A H1N1 WSN33 viruses with different M1 proteins.

Authors:  Zhiguang Ran; Ying Chen; Huigang Shen; Xiaoxiao Xiang; Qinfang Liu; Bhupinder Bawa; Wenbao Qi; Laihua Zhu; Alan Young; Juergen Richt; Wenjun Ma; Feng Li
Journal:  J Gen Virol       Date:  2012-12-19       Impact factor: 3.891

8.  Compatibility among polymerase subunit proteins is a restricting factor in reassortment between equine H7N7 and human H3N2 influenza viruses.

Authors:  Chengjun Li; Masato Hatta; Shinji Watanabe; Gabriele Neumann; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2008-09-24       Impact factor: 5.103

9.  Introduction of a temperature-sensitive phenotype into influenza A/WSN/33 virus by altering the basic amino acid domain of influenza virus matrix protein.

Authors:  Teresa Liu; Zhiping Ye
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

10.  Tyrosine 132 phosphorylation of influenza A virus M1 protein is crucial for virus replication by controlling the nuclear import of M1.

Authors:  Shanshan Wang; Zhendong Zhao; Yuhai Bi; Lei Sun; Xiaoling Liu; Wenjun Liu
Journal:  J Virol       Date:  2013-03-27       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.